Showing results (61-70 of 264) with videos related to
Sort By:
Pageof 27
British Journal of Haematology|June 15, 2005
Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patientsFrancisco Cervantes, Alberto Alvarez-Larrán, Abel Domingo, et al.Blood|September 17, 2005
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 statusPatricia Pérez-Galán, Gaël Roué, Neus Villamor, et al.Leukemia & Lymphoma|September 17, 2004
Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomideClara Montagut, Francesc Bosch, Luís Villela, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradicationFrancesc Bosch, Ana Ferrer, Neus Villamor, et al.Cancer Journal (Sudbury, Mass.)|August 16, 2021
COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand NowThomas Chatzikonstantinou, Yair Herishanu, Emili Montserrat, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 4, 2019
Acquired von Willebrand syndrome in a patient with small lymphocytic lymphoma and Sjögren's syndrome: which associated condition should be prioritized?José Pardos-Gea, Fernanda Martínez, Pau Abrisqueta, et al.European Journal of Haematology|March 27, 2003
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphomaEduardo Arellano-Rodrigo, Armando López-Guillermo, Eric M Bessell, et al.British Journal of Haematology|November 4, 2004
Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literatureFrancisco Cervantes, Alberto Alvarez-Larrán, Juan-Carlos Hernández-Boluda, et al.European Journal of Haematology|March 15, 2006
Bortezomib: an effective agent in extramedullary disease in multiple myelomaRosiñol Laura, Maria Teresa Cibeira, Carla Uriburu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemiaFrancesc Bosch, Pau Abrisqueta, Neus Villamor, et al.Pageof 27